4th Edition of International Precision Medicine Conference
August 17-19, 2023 | Online Event
4th Edition of
International Precision Medicine Conference
Event Book
Event program
Scientific Program
About
Building on the success of the previous editions which drew delegates from all over the world, we now welcome you all once again to join hands in organising the “4th Edition of International Precision Medicine Conference” (Precision Med 2023) in Virtual format from your home or work, during August 17-19, 2023.
Precision medicine (PM) is revolutionising the way medicines are developed, benefiting patients, the pharmaceutical industry, and society as a whole. Precision medicine is a brand-new approach to illness treatment and prevention. Precision medicine strives to establish a personalized and unique treatment and preventative regimen for each patient based on their entire medical profile, including genetic data, medical history, environmental factors, and even lifestyle. It is sometimes referred to as personalized medicine for a reason. The design of a one-of-a-kind treatment necessitates access to almost all of an individual's specific medical data. The pandemic has only served to emphasize the necessity for a flexible and proactive healthcare system. Advances in precision medicine may offer the potential for medical experts to decide the optimal treatment at the correct moment for each person for many diseases that already exist.
Scientific Committee Members
Bernd Blobel
University of Regensburg, Germany
Roy Gary Beran
University of New South Wales, Australia
Matthias Schwab
University of Tubingen, GermanySpeakers
Thomas Webster
Interstellar Therapeutics, United States
Boris Tankhilevich
Magtera, Inc., United States
Isabella Friis Jorgensen
University of Copenhagen, Denmark
Guo Wei He
Tianjin University, China
Juan He
Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine, China
Ekaterina Minskaia
Sirius University of Science and Technology, Russian Federation
Qianqian Song
Wake Forest University School of Medicine, United States
Yuji Yokouchi
Kumamoto University, JapanGallery
Reviews
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Personalized and precision medicine (PPM) can be established as a unique healthcare model through biodesign-driven and inspired biotech, translational applications. This approach aims to ensure human healthcare, wellness, and biosafety.
Sergey Suchkov, Institute for Biotech & Global Health of RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Monitoring folds localization in ultra-thin transition metal dichalcogenides using optical harmonic generation
Ahmed Raza Khan, Australian National University, Australia
Title : A systematic review of regulatory approaches for Direct- To- Consumers (DTC) genetic testing
Kavitha Palaniappan, Duke-NUS Medical School, Singapore
Title : Regulatory framework of in vitro diagnostic and artificial intelligence for precision medicine
Pei Ting Sarah Chou, Regulatory Affairs Professionals Society, Taiwan
Title : Unraveling cancer stem cell signatures in circulating tumor cells of metastatic colorectal cancer: Investigating ALDH1A1 and the repurposing potential of disulfiram via scRNA-seq
Nurul Syakima Ab Mutalib, Universiti Kebangsaan Malaysia, Malaysia